Marcia Sellos-Moura

Marcia Sellos-Moura serves as the Senior Vice President and Head of Development and Program Management at EyePoint Pharmaceuticals since July 2023. Prior to this role, Marcia held the position of Senior Vice President for Strategy and Operations at Flagship Pioneering from December 2021 to July 2023, where Marcia also led Program Planning and Management. Marcia was President at Newbury Biopharma Group for a year and served as Senior Vice President at Orphan Technologies until its acquisition by Travere Therapeutics in November 2020. Marcia's extensive career includes various leadership roles in program and portfolio management at Shire Pharmaceuticals and Transkaryotic Therapies. Marcia earned a PhD in Biochemistry, Molecular and Cell Biology, and a BA in Biochemistry and Chemistry from Cornell University, alongside a Graduate Certificate in Biopharmaceutical International Regulatory Affairs from Northeastern University and completion of the Women's Executive Leadership Program at Bentley University.